TITLE

U.S. v. Charters

AUTHOR(S)
Bourke, Leon H.
PUB. DATE
December 1990
SOURCE
Issues in Law & Medicine;Winter90, Vol. 6 Issue 3, p309
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Presents a United States court ruling holding that antipsychotic drugs may be given over an inmate's objections provided all due process requirements are met. Case of Michael Charters who threatened the life of the president of the United States; Grant for psychiatric evaluation; Forcible subjection.
ACCESSION #
9608053395

 

Related Articles

  • Compulsory Medical Treatment: The Limits of Bodily Integrity. Gostin, Lawrence O. // Hastings Center Report;Sep/Oct2003, Vol. 33 Issue 5, p11 

    Discusses the legality of administering involuntary antipsychotic medication and compulsory treatment on the criminal defendant in the U.S. Court findings in which drugs may be forcibly administered; Use of compulsory treatment; Conflict between free will and state power.

  • Psychiatrists' documentation of informed consent. Schachter, Debbie; Kleinman, Irwin; Schachter, D; Kleinman, I // Canadian Journal of Psychiatry;Dec1998, Vol. 43 Issue 10, p1012 

    Objective: The present study was undertaken to determine current attitudes and behaviour toward informed consent for antipsychotic medication and documentation of the informed consent process in patient charts.Method: Thirty psychiatrists treating a minimum of 10...

  • Haloperidol corners antipsychotic market.  // Drug Topics;11/20/95, Vol. 139 Issue 22, p48 

    Reports on generic haloperidol that accounts for 40 percent of all retail prescriptions written for antipsychotic medications according to data compiled by Scott-Levin Associates. Increase in the number of prescriptions for antipsychotic medications filled by retail pharmacists in the 12-month...

  • Recently asked Questions.  // South African Pharmaceutical Journal;2013, Vol. 80 Issue 4, p38 

    The article presents questions and answers related to the drug atypical antipsychotics including how they developed, challenges associated with them, and which type of the drug is most diabetogenic.

  • New use of antipsychotic drugs in elderly people with dementia may increase the mortality risk.  // Evidence Based Mental Health;May2008, Vol. 11 Issue 2, p54 

    An abstract of the study "Antipsychotic drug use and mortality in older adults with dementia," by S.S. Gill and colleagues is presented.

  • For schizophrenia: Atypical agents offering promise. Alexander, Walter // Drug Topics;6/10/96, Vol. 140 Issue 11, p71 

    Reports on the promise of atypical antipsychotics in offering increased efficacy and reduced side effects in the treatment of schizophrenia and psychosis in other mental illness. Discussion at the 1996 meeting of the American Psychiatric Association; Atypical antipsychotic agents currently...

  • ERRATUM.  // CNS Drugs;2012, Vol. 26 Issue 9, p812 

    A correction to the article "Overdose of atypical antipsychotics: clinical presentation, mechanisms of toxicity and management" in the July 2012 issue is presented.

  • Asenapine.  // Reactions Weekly;9/10/2011, Issue 1368, p9 

    The article describes the case of two men, aged 20 years and 45 years of age, who both presented a 60% improvement in their speech fluency during treatment with asenapine for moderate stuttering, published in the June 2011 issue of the "American Journal of Psychiatry."

  • The Bitterest Pills: The Troubling Story of Antipsychotic Drugs. Mairs, Hilary // Learning Disability Practice;Mar2014, Vol. 17 Issue 2, p10 

    No abstract available.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics